The Flowr Corporation has announced a partnership with cannabis genetics and lifestyle brand, Cookies, to bring its premium strains to the European Union.
Toronto-headquartered cannabis company with operations in Canada and the EU, The Flowr Corporation, has announced that its indirect wholly-owned subsidiary, RPK Biopharma, has entered into a series of agreements with Cookies Creative Consulting and Promotions to bring its premium cannabis products to the EU.
Cookies will assist Flowr with the development of a retail distribution strategy in Portugal through the country’s existing pharmacy networks, as well as the design of up to three proprietary retail pharmacy outlets in the country.
Premium products for the EU
International cannabis brand, Cookies, which cultivates premium genetic strains and which this year launched a new strain with Snoop Dogg, the Doggy Bagg, was founded by grow expert Jai Chang, and entrepreneur and rapper, Gilbert Milam Jr. (Berner). Its Girl Scout Cookies cannabis strain is one of the most sought-after strains in the world and the brand extends beyond cannabis as a clothing and lifestyle brand.
Under the terms of the agreements, RPK (a wholly-owned subsidiary of Holigen Holdings Limited) will be cultivating and distributing Cookies products in Portugal from its 25,000 square foot indoor EU GMP facility in Sintra. It will also have the exclusive rights to sell Cookies branded products, including non-cannabis merchandise, in Portugal for three years subject to milestone commitments.
Flowr CEO, Darryl Brooker, said: “We will be growing the most recognisable cannabis strains in the world in Portugal, including Gary Payton, Cereal Milk, Gelatti, Pancakes and Pink Runtz. As we do in Canada, we want our operations in Portugal to cultivate only ultra-premium medical cannabis and a partnership with Cookies was a no brainer for the company.
“We cannot wait to grow the Cookies branded genetics and proudly display their brand. Establishing this partnership is the next step in the evolution of our business in the EU and will provide us with a competitive advantage in the fast-growing EU medical cannabis market.”
“The fact Portugal decriminalised drugs back in the early 2000’s and people in the US are still being locked up for cannabis 20 years later, shows the world, especially the US, that we can learn a lot from their forward thinking,” added Berner, co-founder and CEO of Cookies.
“The partners we chose in Portugal have one of the most advanced facilities I’ve seen and will be producing some of the best cannabis in the world. It’s partnerships like this that keep me excited about the growth and expansion of Cookies worldwide.”
Cookies has a commitment to restorative justice and progressive drug policy and works to enrich communities disproportionately impacted by the War on Drugs through advocacy work and social equity initiatives. Its products are currently available in the United States, Canada, Israel and Spain.
Flowr has begun the process of importing the Cookies branded genetics from Canada into Portugal and expects to be able to commence commercial production by the end of the year.
[activecampaign form=31]
